Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Z Gastroenterol

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    August 2017
  1. REINSHAGEN M, Stallmach A
    [Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial].
    Z Gastroenterol. 2017;55:779-780.
    PubMed     Text format    


    June 2017
  2. MONASTERIO C, Schmitt-Graff A, Pohl M, Truschel T, et al
    Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab.
    Z Gastroenterol. 2017 Jun 27. doi: 10.1055/s-0043-111805.
    PubMed     Text format     Abstract available


    January 2017
  3. BOKEMEYER B, Dignass A, Schreiber S
    [Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists].
    Z Gastroenterol. 2017 Jan 5. doi: 10.1055/s-0042-121520.
    PubMed     Text format     Abstract available


  4. HELWIG U
    [Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease].
    Z Gastroenterol. 2017;55:85.
    PubMed     Text format    


    December 2016
  5. BETTENWORTH D
    [Evolution of clinical trial design investigating biological therapies in patients with inflammatory bowel disease - implications for clinical practic].
    Z Gastroenterol. 2016.
    PubMed     Text format    


    October 2016
  6. SIEGMUND B, Atreya R, Bokemeyer B, Kruis W, et al
    [Biosimilars in inflammatory bowel disease].
    Z Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  7. GEHRMANN U, Berger U, Teich N, Bruns T, et al
    Motivation of patients with inflammatory bowel disease to participate in a clinical trial.
    Z Gastroenterol. 2016;54:1123-1129.
    PubMed     Text format     Abstract available


    September 2016
  8. RUDDEL J, Schleenvoigt BT, Schuler E, Schmidt C, et al
    Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report.
    Z Gastroenterol. 2016;54:1081-4.
    PubMed     Text format     Abstract available


    May 2016
  9. OTT C
    [News on the impact of Methotrexate as therapeutic option in patients with ulcerative colitis].
    Z Gastroenterol. 2016;54:454-5.
    PubMed     Text format    


    February 2016
  10. LANGBRANDTNER J, Raspe H, Huppe A
    [Employees with chronic diseases - additional results of randomized controlled trial among adult members of a German statutory health insurance with inflammatory bowel diseases].
    Z Gastroenterol. 2016;54:139-45.
    PubMed     Text format     Abstract available


    October 2015
  11. SCHACK S, Weber M, Oelzner P, Mireskandari M, et al
    [Morbus Behcet or inflammatory bowel disease - a diagnostic and therapeutic dilemma].
    Z Gastroenterol. 2015;53:1187-92.
    PubMed     Text format     Abstract available


    September 2015
  12. MOESER A, Pletz MW, Hagel S, Kroegel C, et al
    Lung disease and ulcerative colitis - mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease?
    Z Gastroenterol. 2015;53:1091-1098.
    PubMed     Text format     Abstract available


    August 2015
  13. HAUSMANN J, Blumenstein I
    [Gender differences and inflammatory bowel disease].
    Z Gastroenterol. 2015;53:774-8.
    PubMed     Text format     Abstract available


    May 2015
  14. SCHREIBER S, Dignass AU, Hartmann H, Kruis W, et al
    [Current position on Vedolizumab for ulcerative colitis and Crohn's disease].
    Z Gastroenterol. 2015.
    PubMed     Text format     Abstract available



  15. [Professional and private loadable -- despite ulcerative colitis: With Mezavant 1 x daily noticeable therapeutic success ].
    Z Gastroenterol. 2015;53:2 p following 523.
    PubMed     Text format    


    January 2015

  16. [Joint opinion of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Internal Medicine (DGIM) to Vedolizumab-benefit assessment according to section sign 35a SGB V the G-BA].
    Z Gastroenterol. 2015;53:54-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: